This study is testing a new approach using a 'chatbot' (a computer program that talks like a human) to help identify people who might be at higher risk for hereditary cancer syndromes, especially gynecologic cancers. The chatbot will have text-like conversations with patients to gather information. Researchers want to see if using this chatbot can lead to more people being recommended for genetic testing compared to standard care. They are also looking at what might make it harder or easier for patients to get genetic testing. You can join if you are 18 or older, speak English, have a phone with texting, and haven't had genetic testing for hereditary cancer before. The study aims to enroll 150 participants.

Study design

This interventional study plans to enroll 150 participants. It compares a chatbot system to usual care to see if it improves recommendations for genetic testing.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will measure the proportion of participants recommended for genetic testing at 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.